LPL Financial »

Diamedica Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $589k 141k 4.19
2024-06-30 $52k 18k 2.95

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)

View all positions for LPL Financial

Top funds holding Diamedica Therapeutics

Vanguard Group
First Manhattan
Paragon Associates & Paragon Associates Ii Joint Venture
Bleichroeder
Geode Capital Management
LPL Financial
Northern Trust
BlackRock
BlackRock
Susquehanna International
Morgan Stanley
State Street Corporation
Ronald Blue Trust
Catalyst Financial Partners
Citigroup

View all funds holding Diamedica Therapeutics